Andy Burr is vice president and infectious and respiratory diseases (IRD) therapeutic unit head with responsibility for strategic direction, business operations and operational delivery of PPD’s IRD therapeutic unit. He brings a 30-year career of extensive project management, development operations, and leadership experience to the oversight of his large and growing IRD team. In addition to infectious and respiratory diseases Andy’s expertise includes academic research in hepatic disease, and operational delivery in cardiovascular, metabolic, and critical care diseases.